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Objectives: to study the course of postoperative acute renal failure requiring renal replacement therapy (RRT) in patients
with ruptured (RAAA) and non-ruptured (EAAA) aneurysm of the abdominal aorta (AAA) and to investigate the
predictive value regarding outcome of parameters collected during the illness.
Design: retrospective study in a university hospital.
Materials and methods: the records of 42 patients, 21 with RAAA and 21 with EAAA, were reviewed.
Results: overall mortality was 69%, 71% for RAAA patients and 66% for EAAA patients. RRT was started 9 (2–28)
days – median (range) – postoperatively and continued during 9 (2–50) days. Renal function recovered in nine of the 13
survivors after 18 (2–50) days. Length of ICU stay was 50 (2–132) days for survivors vs. 19 (6–56) days for non-
survivors. The systemic inflammatory response syndrome (SIRS) or need for vasoactive support was associated with poor
outcome and the ability to wean from vasoactive or ventilatory support with improved outcome.
Conclusions: RAAA and EAAA patients requiring postoperative RRT both had a high mortality. The ICU stay of non-
survivors was shorter than that of survivors, who had a 75% chance of regaining renal function. The ability to wean
from ventilatory and inotropic support may be of help in the clinical management of patients requiring RRT after AAA
surgery.
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Introduction no scoring system or logistic regression model can
predict survival in patients with ARF with enough
The mortality of patients with acute renal failure after accuracy to be of use in decisions concerning in-
dividual patients.9–11 These scoring systems and logisticAAA surgery remains high; mortality rates of 58% to
86% have been found recently in patients requiring regression models generally take into account factors
that are present at the beginning of the illness, but therenal replacement therapy (RRT) after surgery for rup-
tured aneurysm of the abdominal aorta (RAAA).1–4 For appropriateness of this approach may be questioned,
as evidence is accumulating that renal failure in thepatients requiring RRT after elective abdominal aortic
aneurysm (EAAA) surgery, only small numbers have ICU is often part of systemic disease evolving over
time and not an isolated single-organ problem.12–15 Itbeen reported but these suggest a similar high mor-
tality of approximately 65%.1,2,5–8 Few detailed data are could therefore be of value to identify factors signifying
systemic disease as well as factors that correlate withavailable concerning the course in time and recovery
of renal function following acute renal failure (ARF) success or failure of treatment in patient populations
in which renal failure is investigated. These factorsin the setting of abdominal aneurysm surgery. This is
regrettable, since this information may be relevant to may be present at onset of disease but, assuming that
severe illness is a dynamic process, might also bethe clinical management of these patients. The high
mortality of critically ill patients requiring RRT has identified during the course of the disease, as defining
success or failure of treatment is often not possible inprompted a search for ways of differentiating between
potential survivors and non-survivors but at present the early phase of illness.
In a retrospective analysis of patients receiving RRT
after ARF following AAA surgery we addressed the
* Please address all correspondence to: R. Braams, Surgical Intensive following issues: mortality (for the group as a wholeCare Unit, University Hospital Utrecht, Heidelberglaan 100, 3584
CX Utrecht, The Netherlands. as well as for subgroups RAAA and EAAA patients),
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Table 1. Patient characteristics (n=42).
RAAAe (n=21) EAAAf (n=21) All patients (n=42)
Age (years) 70 (56–82)* 67 (58–76)* 69 (56–82)*
Sex (male/female) 19/2 19/2 38/4
ASA II/IIIa – 14/7 14/7
APACHE IIb 23 (12–30)* – 23 (12–30)*
APACHE II start RRTc 20 (16–28)* 20 (14–29)* 20 (14–29)*
Blood loss (millilitres) 5000 (2000–15 000)* 2500 (500–7500)* 4800 (500–15 000)*
Referred preoperatived 6 6 12
Referred postoperatived 5 8 13
Reoperation <48 h 14 8 22
ICU stay (days) 20 (4–132)* 22 (2–106)* 20 (2–132)*
Ward stay (days) 16 (2–58)* 25 (18–100)* 22 (2–100)*
Hospital stay 21 (4–202)* 31 (11–164)* 30 (4–202)*
Mortality 71% (n=15) 66% (n=14) 69% (n=29)
*Numbers are given as median (range).
a ASA: American Society of Anesthesiologists (classification according to).
b APACHE II: Acute Physiology and Chronic Health Evaluation II.
c RRT: Renal replacement therapy.
d Referred: – preoperative: complicated operation expected or lacking expertise in referring hospital,
– postoperative: no dialysis expertise in referring hospital.
e RAAA: Ruptured aortic abdominal aneurysm.
f EAAA: Elective aortic abdominal aneurysm.
specific renal failure-related data such as time of onset, and clinical course, specific data concerning the renal
failure were collected as well as the simultaneousnumber of dialysis procedures and course of recovery
of renal function. Finally, we looked for evidence occurrence of the systemic inflammatory response
syndrome (SIRS), defined according to the Americanto support the hypothesis that outcome parameters
collected during the course of the disease might be of College of Chest Physicians critical care consensus
conference.16 Also the ability to wean from inotropic orvalue in predicting outcome.
ventilatory support successfully during RRT (inotropic
support being defined as the use of noradrenaline,
dobutamine or dopamine >5 lg/kg/min) was in-
Materials and Methods vestigated. Values are expressed as median (range)
unless stated otherwise. Statistical analysis was per-The records of all patients receiving RRT after ruptured formed using Fisher’s exact test and Student’s t-testor elective AAA repair between 1987 and 1997 were where appropriate. Significance was defined asexamined. Patients with pre-existing renal impairment,
pZ0.05.defined as a serum creatinine higher than 133 mmol/l,
were excluded. A total of 42 patients were studied, of
whom demographic data are summarised in Table 1.
The cause of renal failure was considered to be acute Results
tubular necrosis (ATN) unless the data available
offered an alternative diagnosis. RRT consisted of The mortality for the group as a whole was 69% (29/
42), no difference in mortality being observed betweeneither intermittent haemodialysis and ultrafiltration or
CAVHD, or a combination of both. Indications for patients with RAAA (71%; 15/21) and EAAA (66%;
14/21). The APACHE II score at admission for patientsstarting RRT were fluid overload, a serum potassium
level above 6 mmol/l, or complications attributed to with RAAA was 23 (12–30), patients with EAAA were
ASA II and III; at the start of RRT median APACHEelevated serum urea such as pericarditis, gastritis or
bleeding complications. Early renal failure was defined II scores for both groups were 20. Of the 42 patients,
25 were referred from other hospitals either pre- oras the necessity of dialysis within 10 days of operation,
late renal failure as the necessity of RRT after this postoperatively. For the group as a whole the ICU
stay was 20 (2–132) days with no significant differenceperiod. Recovery of renal function was defined as the
lack of continuing necessity for RRT. between RAAA and EAAA patients. The length of
ICU stay for survivors was 50 (2–132) days and forApart from patient demographic data, operative
details, length of stay, severity of illness (APACHE II non-survivors 19 (6–56) days. Of the 42 patients 40
were considered to have ATN, necessitating RRT afterfor RAAA patients and ASA score for EAAA patients)
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Table 2. RRT a data. 10 without inotropic support (p=0.01); of the 24
patients not able to be weaned from inotropic support
All patients (n=42) during their stay in the ICU, none survived compared
Creatinine start dialysis (lmol/l) 610 (241–1009)* with five survivors among the eight patients who
Urea start dialysis (mmol/l) 46 (16–79)* could be weaned off inotropic support (p=0.007); all
ATNb 40 25 patients who could not be weaned off the ventilatorCAVHDc 21
Dialysis/ultrafiltration 21 died compared with four of the 17 patients who could
Both 11 be successfully weaned (p=0.001). Age was not a
Days of RRT 9 (2–26)* prognostic factor concerning outcome in the patientsDt operation – RRT (days)d 9 (2–28)*
Dialysis Z10 days postop. 27 studied.
Dialysis >10 days postop. 15
Recovery kidney function 11
Dt recovery (days)e 18 (5–50)*
*Numbers are given as median (range).
Discussiona RRT: renal replacement therapy.
b ATN: acute tubular necrosis.
c CAVHD: continuous arterio venous haemofiltration/dialysis. When assessing mortality of patients after AAA repaird Dt operation – RRT: time interval between operation and start RRT.
requiring postoperative RRT it is instructive to observee Dt recovery: time interval renal recovery (defined as days from
start until termination of RRT). the mortality rate of critically ill ICU patients needing
RRT. Despite the fact that over the years intensive care
monitoring, support and resuscitation techniques asa median of 9 days (2–26) postoperative; in nine of 13
survivors recovery of renal function occurred. The well as RRT techniques have improved, the mortality
of mixed populations of ICU patients requiring RRTinterval for renal function recovery was 18 days (2–50).
For detailed data concerning RRT see Table 2. Dif- has remained high, as evidenced by a recent report
showing a hospital mortality of 58%.14 However, itferences in the presence of systemic inflammatory
response syndrome (SIRS) and the necessity of ino- is becoming clear that differences exist in mortality
between specific patient groups, for example mortalitytropic support at the onset of RRT as well as a difference
in the capability to be weaned from ventilatory and in trauma patients requiring RRT appears to be lower
than mortality in patients with RAAA requiring RRT.17inotropic support between survivors and non-sur-
vivors were found: 25 of 30 patients with SIRS at the The fact that different patient categories with RRT
show different mortality suggests that the patient andonset of dialysis died as against four out of 12 without
SIRS (p=0.05); 27 of 32 patients needing inotropic the disease, rather than the renal failure, determine
the outcome. When comparing different groups ofsupport at onset of dialysis died as against two out of
Table 3. Results.
All patients Survivors Non-survivors p-value
(n=42) (n=13) (n=29)
Age (years) 69 (56–82)* 69 (58–77)* 70 (56–82)*
Sex (male/female) 38/4 11/2 27/2
ASA II/IIIa 14/7 6/1 8/6
APACHE IIb 23 (12–30)* 20 (16–27)* 24 (12–30)*
Reoperation <48 h 22 5 17
ICU stay (days) 20 (2–132)* 50 (2–132)* 19 (6–56)*
Ward stay (days) 22 (2–100)* 25 (12–70)* 18 (2–100)*
SIRSc + 30 5 25 p=0.05
SIRS - 12 8 4
Inotropic support + 32 5 27 p=0.01
Inotropic support - 10 8 2
Weaning inotropic support + 8 5 3 p=0.007
Weaning inotropic support - 24 0 24
Weaning ventilator + 17 13 4 p=0.001
Weaning ventilator - 25 0 25
Recovery renal function + 11 9 2
Recovery renal function - 31 4 27
*Numbers are given as median (range).
a ASA: American Society of Anesthesiologists (classification according to).
b APACHE II: Acute Physiology and Chronic Health Evaluation II.
c SIRS: Systemic inflammatory response syndrome.
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patients, or even patient groups with identical diag- wide range in days spent in the ICU, there will be
noses such as RAAA, it is therefore crucial to be patients who spend 4–8 weeks in the ICU on renal
informed about specific patient characteristics such support before dying. In a recent study evaluating
as diagnosis, patient selection, age, chronic disease, mortality-related factors in patients developing ARF
operative complications and severity of illness, in the after admission to the ICU, patients with delayed ARF
form of a score. had higher mortality than patients with renal failure
The mortality of 75% in our patients with RAAA present at admission to the ICU.7,11,14,19 The authors
requiring RRT is in agreement with previous literature. attribute this to worsening of the clinical condition
Data concerning mortality in patients with EAAA despite supportive therapy. A comparable pattern was
requiring RRT are scarce and concern only small num- found in our patients with higher mortality in the
bers of patients ranging from 4–14.1,2,5–8 The combined late (13/15) vs. the early (16/27) renal failure group,
mortality of these patient studies is 65% (28/43) which although the difference did not reach statistical sig-
is comparable to the mortality of 68% (15/22) which nificance. This, and the fact that the presence of SIRS
we found in our patients. Several factors contribute to in 30 patients at the start of RRT was associated with
the high mortality in our patients with EAAA and increased mortality: 25/30 vs. 4/12 in patients without
RRT: the preoperative condition reflected in an ASA SIRS (p=0.05), lends support to the hypothesis that
score of 2–3, and the fact that the majority had op- renal failure in critically ill patients is often an epi-
erative complications leading to substantial blood loss phenomenon of progressive systemic disease. This has
and in eight cases reoperation within 24 h. Selection led to interest in the possibility of developing scoring
bias may also have played a role, as eight patients systems that not only use initial but also repeated
were referred postoperatively from other hospitals physiologic measurements.20,21 In pursuit of this line,
because of their deteriorating renal function. In the we looked for clinical parameters that, when re-
end, however, patients with EAAA and RRT develop peatedly measured, might be indicative of a response
the same degree of systemic illness as the RAAA to treatment. The ability to be weaned from the ventil-
patients with RRT, explaining the similar mortality. ator and from inotropic/vasopressor support were two
The reason that mean serum urea and creatinine are factors chosen because of their reflection of systemic
high at the start of RRT can be attributed to the fact disease, their association with poor outcome2,8,11,22,23
that only a minority of the patients had an anuric ARF, and objective verification.
and our policy was to refrain from RRT (in the absence Our results suggest that the presence of systemic
of uraemic complications) as long as fluid and elec- disease requiring vasoactive support is correlated with
trolyte balance could be maintained. Although the increased mortality. Although the need for vasoactivecriteria for dialysis may appear diverse, they guarantee
support at onset of RRT seems to indicate a worsethat the indication for dialysis is absolute and not
outcome for this group, five patients survived, pre-relative. In our population no difference in urea and
sumably because in time these patients managed tocreatinine at onset of RRT was found between sur-
reverse their underlying disease, something that is notvivors and non-survivors. For the group as a whole
taken into account when vasoactive support is scoredRRT was instituted for a period of 9 (2–50) days, 11 days
once at the onset of the disease. Using the ability toin survivors and 8 days in non-survivors. Recovery of
be weaned from inotropic support during the courserenal function was seen in nine of 13 survivors; five
of the disease as a marker of response to therapyin RAAA and four in EAAA patients. This is in
appears to reflect more accurately the chances of sur-accordance with recovery rates of 50–84% found in
vival. This also holds true for the ability to be weanedother series of patients surviving RRT after AAA sur-
from ventilatory support. The fact that in our smallgery7,11,18 implying that, if a patient survives, the
retrospective study, patients who were able to bechances of renal recovery are similar to mixed ICU
weaned from inotropic and ventilatory support didpopulations where renal recovery of 65% after sur-
better than those that were not is hardly surprising,viving ARF has been reported.19 In the patients with
but does lend support to the hypothesis that factorsrenal recovery this occurred after a median of 18 days
reflecting the course of the disease may be more ap-(range 5–50) which is between the 13 and 27 days
propriate in predicting outcome than factors ex-previously reported in similar patient populations.11,18
clusively present at the onset of disease.The fact that non-survivors had a shorter stay in the
Where does this leave us concerning prognosis andICU than did survivors is in accordance with previous
management of the patient with renal failure afterobservations18 and suggests that patients offered RRT
(R)AAA surgery? Central in the approach to thesewho ultimately do not survive do not use a dis-
proportional amount of ICU capacity, but, given the patients should be the knowledge that (late) renal
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